Filter
86
Filtered Results: 86
Text search:
DNDi
Featured
Recommendations
8
New Publications
20
Language
Document type
Studies & Reports
27
No document type
20
Guidelines
8
Videos
7
Strategic & Response Plan
7
Resource Platforms
5
Manuals
4
Fact sheets
4
Situation Updates
3
Infographics
1
Countries / Regions
Global
11
Latin America and the Carribbean
6
Africa
5
Colombia
3
Ethiopia
3
Kenya
2
West and Central Africa
2
East and Southern Africa
2
Southern Africa
2
Brazil
2
Asia
1
Congo, Democratic Republic of
1
South–East Asia Region
1
North America
1
Uruguay
1
Argentina
1
Bangladesh
1
Uganda
1
Zambia
1
India
1
Authors & Publishers
Publication Years
Category
Studies & Reports
5
Chagas
4
Guidelines
4
Leishmaniasis
4
Statistics
3
Disease Prevention & Control
3
Hepatitis
2
Pediatrics
2
Policies & Guidelines HIV & TB
2
Policies
2
NTDs & Others
2
HIV & STI
2
Pharmacy & Technologies
2
COVID-19
1
Virology
1
Medical Devices & Equipment
1
Drugs & Medical Equipment
1
Parasitology
1
Human African Trypanosomiasis
1
Toolboxes
Capacity Building & Resources
7
Studies & Reports
6
Strategies & Roadmaps
5
Clinical Aspects & Diagnostics
5
Studies & Reports
5
Studies & Reports
4
Clinical Aspects & Diagnostics
3
Local Action
2
Essential Medicines
2
Capacity Building & Resources
2
Information & Education Material (IEC)
2
Statistics & Facts
2
Overview, Studies & Reports
2
Antiretroviral Treatment ART
2
ART Drug Resistance
1
Agriculture & Veterinary
1
HIV testing & services
1
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Clinical Aspects
1
Children & Adolescents
1
Opportunistic Infections
1
Introduction to Global Health
1
Prevention Guidelines
1
Treatment Guidelines HIV
1
Concepts of Global Health
1
Curricula & Core Competencies
1
Children
1
Health Equity & Equality
1
Health Personnel
1
Country specific documents
1
Long COVID/ Post-COVID Syndrome
1
Advocacy & Communication
1
Climate Change General
1
Prices and Patents
1
Chagas
1
Leishmaniasis
1
Capacity Building & Resources
1
Information & Education Material (IEC)
1
Information & Education Material (IEC)
1
NTDs General
1
Vector control
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Information & Education Material (IEC)
1
Access to treatment and laboratory
1
Health Financing Toolbox
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Human Rights & the Right to Health
1
HIV service delivery
1
AMR
1
Reports & Studies
1
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Meeting Report
27–30 June 2017 Manila, Philippines
2nd edition
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address the many outstanding resea...
Cutaneous leishmaniasis is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often asso...
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often...
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often...
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often...
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often...
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin.
The only treatment available for cutaneous leishmaniasis is highly toxic. In some cases, patients have died because of the treatment, even though cutaneous leishmania...
Website last accessed on 14.04.2023
Health workers Luke (Kenya), Juliana (Colombia), and Shishu (India) share the same hope for their patients with leishmaniasis: simple, oral treatments. For the first time ever, it seems leishmaniasis research is moving from neglect to a sense of hope.
